(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

HERNEXEOS

This trademark appears in the official USPTO history.

Even when the status is closed, the history helps calibrate risk, avoid repeating mistakes, and define a safe naming strategy.

CANCELLATION INSTITUTED NO. 999999Type: WordOffice: United States

Quick snapshot

HERNEXEOS

ST13

US500000079378238

Class

5

Filing

79378238

Registration

7628763

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

CANCELLATION INSTITUTED NO. 999999

Case type

Application and registration

Recorded events

27

Latest update

08/12/2026

Trademark type

Word

Nice classes

5

Filing date

07/18/2023

Registration date

12/31/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/27/2026

Last transaction

08/12/2026

Responsible office

United States Patent and Trademark Office

Status code

790

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

DE

Examiner

O'BRIEN, JENNIFER LYNN

Law office

N30

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Boehringer Ingelheim International GmbH

Representatives

MAURY M TEPPER III TEPPER & EYSTER PLLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations for the prevention and treatment of diseases and disorders and of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular systemmusculoskeletal systemcentral nervous systemperipheral nervous systemgenitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disordersdamaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections; pharmaceutical preparations for the prevention and treatment of oncological and auto-immune diseases and disorders; pharmaceutical preparationscell based immune therapeutics for treatment of cancerfor treatment of immunological diseasestreatment of infectious diseases

Publications

History of USPTO decisions and trademark events.

27 publications found

PETC

CANCELLATION INSTITUTED NO. 999999

07/27/2026

FINV

FINAL DECISION TRANSACTION PROCESSED BY IB

07/11/2025

FICS

FINAL DISPOSITION NOTICE SENT TO IB

06/24/2025

FIMP

FINAL DISPOSITION PROCESSED

06/24/2025

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

03/31/2025

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

03/01/2025

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

02/10/2025

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

02/08/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/31/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

12/31/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/12/2024

PUBO

PUBLISHED FOR OPPOSITION

11/12/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/23/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/01/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/26/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/26/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/26/2024

RFNT

REFUSAL PROCESSED BY IB

04/24/2024

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

03/29/2024

RFRR

REFUSAL PROCESSED BY MPU

03/29/2024

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

03/12/2024

CNRT

NON-FINAL ACTION WRITTEN

03/11/2024

DOCK

ASSIGNED TO EXAMINER

03/09/2024

MAFR

APPLICATION FILING RECEIPT MAILED

09/19/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/15/2023

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

09/13/2023

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

09/07/2023

Continuous trademark protection

Get notified about every new filing that threatens HERNEXEOS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.